CompanyDrug

Luye Pharma’s Rotigotine Microspheres Meet Phase III Goals in Parkinson’s Study

CompanyDrug

Eli Lilly’s Retevmo Wins Special Approval in China’s Lecheng Medical Pilot Zone

CompanyDeals

Attec Completes Pre-Series A Financing with Sequoia China Backing Protein Degradation Tech

CompanyDrug

Innovent Biologics’ Mazdutide Meets Phase II Goals in Type 2 Diabetes Study

CompanyDeals

Digital Precision Medicine Raises Hundreds of Millions in Series B Financing for Molecular Imaging Innovation

CompanyDrug

Sihuan Pharma’s Fourth-Gen Insulin Degludec NDA Accepted by NMPA for Review

CompanyDrug

Sihuan Pharma’s Anaprazole Enters Phase II Study for Reflux Esophagitis

CompanyR&D

Takeda Opens R&D Asia-Pacific Headquarters in Shanghai to Boost Drug Development

CompanyDeals

Tongling Bionic Raises Hundreds of Millions in Series B Financing for Cardiopulmonary Equipment Development

CompanyDrug

Sesen Bio Terminates Vicineum Development After FDA Talks, Citing Phase III Costs

CompanyMedical Device

Huadong Medicine’s GFR Monitoring System Accepted by NMPA for Review

CompanyDrug

Roche’s Chugai Launches Edirol in China for Postmenopausal Osteoporosis